Health and Fitness Health and Fitness
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure
[ Mon, Oct 24th 2011 ] - Market Wire
Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow
[ Mon, Oct 24th 2011 ] - Market Wire
Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation
Sat, October 22, 2011
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon
[ Sat, Oct 22nd 2011 ] - Market Wire
Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC
Fri, October 21, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Biogen Idec e Abbott presentano i risultati posit .. ;esperimento di fase 2B sul Daclizumab HYP pr
[ Fri, Oct 21st 2011 ] - Market Wire
Biogen Idec e Abbott presentano i risultati posit .. di fase 2B sul Daclizumab HYP presso ECTRIMS/ACTR
[ Fri, Oct 21st 2011 ] - Market Wire
Biogen Idec and Abbott Present Positive Data for .. HYP from Select Phase 2B Trial at ECTRIMS/ACTRIMS
[ Fri, Oct 21st 2011 ] - Market Wire
Cantel Medical Board of Directors Authorizes Increase in Semiannual Dividend
[ Fri, Oct 21st 2011 ] - Market Wire
Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P
[ Fri, Oct 21st 2011 ] - Market Wire
Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America
[ Fri, Oct 21st 2011 ] - Market Wire
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Critical Outcome Technologies Inc. Announces Warrant Term Amendments
[ Fri, Oct 21st 2011 ] - Market Wire
2011 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide
[ Fri, Oct 21st 2011 ] - Market Wire
Anacor Pharmaceuticals to Present at the 10th Annual Bio Investor Forum
[ Fri, Oct 21st 2011 ] - Market Wire
PharmaGap Completes Placement of Equity Units
[ Fri, Oct 21st 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in K-V Pharmaceutical Company to Inquir
[ Fri, Oct 21st 2011 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp
[ Fri, Oct 21st 2011 ] - Market Wire
Allos Therapeutics Announces Termination of Merger Agreement with AMAG Pharmaceuticals
[ Fri, Oct 21st 2011 ] - Market Wire
AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger
[ Fri, Oct 21st 2011 ] - Market Wire
Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance
[ Fri, Oct 21st 2011 ] - Market Wire
Medicure Announces Graduation to TSX Venture Exchange
[ Fri, Oct 21st 2011 ] - Market Wire
Volatility Grows in Biotech Sector -- Keryx and AVI BioPharma Need to Put Up Results
[ Fri, Oct 21st 2011 ] - Market Wire
For The Earth Corporation Strengthens Its Portfolio With Kat Box King
[ Fri, Oct 21st 2011 ] - Market Wire
AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si
[ Fri, Oct 21st 2011 ] - Market Wire
Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan
[ Fri, Oct 21st 2011 ] - Market Wire
Additional Data From Pfizera?s Prevnar 13® Clini .. And Older To Be Presented At The 49th Annual Meet
[ Fri, Oct 21st 2011 ] - Market Wire
Horizon Pharma to Ring the NASDAQ Stock Market Closing Bell on October 24, 2011

Horizon Pharma to Ring the NASDAQ Stock Market Closing Bell on October 24, 2011


Published on 2011-10-21 04:37:37 - Market Wire
  Print publication without navigation


October 21, 2011 07:30 ET

Horizon Pharma to Ring the NASDAQ Stock Market Closing Bell on October 24, 2011

DEERFIELD, IL--(Marketwire - Oct 21, 2011) - Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) today announced that the Company's chairman, president and chief executive officer, Timothy P. Walbert, is scheduled to preside over the NASDAQ Closing Bell Ceremony in New York on Monday, October 24, 2011 at 4:00 p.m. ET. Horizon's common stock began trading on the NASDAQ Global Market on July 28, 2011 under the symbol "HZNP."

"We are honored to have been asked to ring the NASDAQ Stock Market Closing Bell," Mr. Walbert stated. "The past six months have been transformative for Horizon, during which time we have been transitioning the Company, with our first product approval in the U.S., into a fully integrated commercial organization and gained a listing on NASDAQ."

A live webcast of the Closing Bell Ceremony will begin at 3:50 p.m. ET and can be viewed via the MarketSite Webcam by launching the link: [ http://www.nasdaq.com/about/marketsitetowervideo.asx ].

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit [ www.horizonpharma.com ].


Contributing Sources